Join the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationMeeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 18-19 January 2022
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 13 January 2022
In December 2021, the European Medicines Agency (EMA) published the draft of the "Guideline on the acceptability of names for human medicinal products processed through the centralised procedure" for public comment on their website.
Regulatory harmonisation of clinical trials in the EU: Clinical Trials Regulation to enter into application and new Clinical Trials Information System to be launched
FDA Year in Review 2021
The MHRA are consulting on a set of proposals to improve and strengthen the UK clinical trials legislation to help make the UK the best place to research and develop safe and innovative medicines.
Invitation to the webinar launch event for the Regulatory Science Research needs on 18 January 2022
The European Medicines Agency has published for public consultation on the ICH harmonised guideline on Quality Risk Management Q9 (R1).
EMA - Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 13-16 December 2021
The Medicines and Healthcare products Regulatory Agency (MHRA) assesses its regulatory impact on businesses.